guillain-barré

  1. SWAlexander

    COVID-19 post vaccination neuronal adverse events: probable mechanisms and treatment possibilities

    Early in the COVID-19 pandemic, a few cases of affected individuals with SARS-CoV-2 infection and neurological deficits were observed, but it was not until late 2020/early 2021 that these cases were validated as NeuroCOVID and SARS-CoV-2 were implicated in neuroinflammation and possible direct...
  2. SWAlexander

    Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19

    Abstract High levels of autoimmune antibodies are observed in COVID-19 patients but their specific contribution to disease severity and clinical manifestations remains poorly understood. We performed a retrospective study of 115 COVID-19 hospitalized patients with different degrees of severity...
Back